FdaApplication
BLA 019959
Identifiers
- fda_app_no: BLA019959
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 1991-07-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOVOLIN N | INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | 1,000UNITS/10ML (100UNITS/ML) | Injectable Suspension |
| NOVOLIN N | — | 300UNITS/3ML (100UNITS/ML) | Injectable Suspension |
2 products